INFLAMMATION’s cognitive impact revealed by a novel “Line of Identity” approach

Producción científica: Articlerevisión exhaustiva


Importance Dementia is an “overdetermined” syndrome. Few individuals are demented by any single biomarker, while several may independently explain small fractions of dementia severity. It may be advantageous to identify individuals afflicted by a specific biomarker to guide individualized treatment. Objective We aim to validate a psychometric classifier to identify persons adversely impacted by inflammation and replicate it in a second cohort. Design Secondary analyses of data collected by the Texas Alzheimer’s Research and Care Consortium (TARCC) (N = 3497) and the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (N = 1737). Setting Two large, well-characterized multi-center convenience samples. Participants Volunteers with normal cognition (NC), Mild Cognitive Impairment (MCI) or clinical “Alzheimer’s Disease (AD)”. Exposure Participants were assigned to “Afflicted” or “Resilient” classes on the basis of a psychometric classifier derived by confirmatory factor analysis. Main outcome(s) and measure(s) The groups were contrasted on multiple assessments and biomarkers. The groups were also contrasted regarding 4-year prospective conversions to “AD” from non-demented baseline diagnoses (controls and MCI). The Afflicted groups were predicted to have adverse levels of inflammation-related blood-based biomarkers, greater dementia severity and greater risk of prospective conversion. Results In ADNI /plasma, 47.1% of subjects were assigned to the Afflicted class. 44.6% of TARCC’s subjects were afflicted, 49.5% of non-Hispanic Whites (NHW) and 37.2% of Mexican Americans (MA). There was greater dementia severity in the Afflicted class [by ANOVA: ADNI /F (1) = 686.99, p <0.001; TARCC /F(1) = 1544.01, p <0.001]. “INFLAMMATION” factor composite scores were significantly higher (adverse) in Afflicted subjects [by ANOVA in ADNI /plasma F(1) = 1642.64, p <0.001 and in TARCC /serum F(1) = 3059.96, p <0.001]. Afflicted cases were more likely to convert to AD in the next four years [by Cox’s F, ADNI /plasma: F (252, 268) = 3.74 p < 0.001; TARCC /serum: F (160, 134) = 3.03, p < 0.001 (in TARCC’s entire sample), F (110, 90) = 4.92, p <0.001 in NHW, and F(50, 44) = 2.13, p = 0.006 in MA]. The proportions converting were similar among afflicted NHW in both cohorts /biofluids but MA exhibited a lower risk (7% in TARCC /serum at 48 months). Conclusions and relevance Our inflammation-specific psychometric classifier selects individuals with pre-specified biomarker profiles and predicts conversion to “AD” across cohorts, biofluids, and ethnicities. This algorithm might be applied to any dementia-related biomarker making the psychometric estimation of individual biomarker effects feasible without biomarker assessment. Our approach also distinguishes individuals resilient to individual biomarker effects allowing for more accurate prediction and precision intervention.

Idioma originalEnglish (US)
Número de artículoe0295386
PublicaciónPloS one
N.º3 March
EstadoPublished - mar 2024

ASJC Scopus subject areas

  • General


Profundice en los temas de investigación de 'INFLAMMATION’s cognitive impact revealed by a novel “Line of Identity” approach'. En conjunto forman una huella única.

Citar esto